Valentin Gapontsev Trust I sold $2.1M of IPGP

Valentin Gapontsev Trust I sold 27,397 shares of IPG PHOTONICS CORP (IPGP) at an average of $75.42 ($75.14–$76.25, $2.07M total) across 3 trades over 2026-09-01 to 2026-09-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Valentin Gapontsev Trust I
Published Sep 3, 2026, 8:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 3, 2026, 11:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$IPGP
Bearish
medium confidence
Mentioned
$IPGP
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IPGPBearishLow
01

Why it matters

The insider sale provides fresh data on ownership changes, useful for short‑term traders monitoring insider sentiment.

02

Market read

First‑report insider sale; modest size but material holder, may influence short‑term price action.

03

What to watch

Potential tax planning or portfolio rebalancing unrelated to company fundamentals.

Relevance 5/10Novelty 7/10Timing: filed Sep 3 2026 (post‑market)

Background

IPG Photonics Corp (NASDAQ:IPGP) is a leading provider of high‑performance lasers and photonics solutions.

Company-level read

Ticker impact

$IPGPBearishMedium confidence
Context

Form 4 filing shows Valentin Gapontsev Trust I sold 27,397 shares for $2.07M, reducing its stake to 6.64M shares.

Expected impact

Modest short‑term downside pressure, 1‑2% dip expected.

Evidence & confidence

The sale size is modest relative to market cap, but the insider holds a material stake; market may react cautiously.

Market effects

Minimal impact on photonics sector; insider activity is company‑specific.

No broader regional effect.

Limited to investors tracking IPGP.

Counterpoint

The sale could be a routine liquidity move, not a negative signal.

Key entities

  • Valentin Gapontsev Trust I

    10% owner of IPGP filing a Form 4 sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$IPGPMed

Why IPG Photonics (IPGP) shares are falling today

IPG Photonics (IPGP) shares fell 9.8% after Democratic senators called for slowing AI data center development, impacting chipmakers. Micron paused a $4.5B plant in Taiwan due to labor disputes. IPGP is down 15.9% YTD, trading 59.2% below its 52-week high. Rising Treasury yields also weigh on semiconductor stocks.

$IPGPMed

IPG Photonics Corp (IPGP) (Q3 2026) Earnings Call Highlights: Fourth Straight Quarter

IPG Photonics (IPGP) expects Q4 revenue of $265-$295M, with adjusted gross margin declining to 37-40% due to lower tariff refunds. European sales fell 1% YoY, while defense revenue is lumpy. CEO Dr. Mark Gitin sees long-term growth in battery, semiconductor, and medical sectors. CFO Timothy Mammen notes cost pressures but expects gross margin improvements in 2027. Medical and semiconductor are key growth drivers.

$IPGPLow

IPG Photonics (IPGP) Beat Q3 Estimates, Is It Still Below Fair Value?

IPG Photonics (IPGP) reported Q3 2026 sales of $287.5M and net income of $20.27M, beating estimates. Despite this, shares fell 11.46% in 30 days and 11.40% over 1 year. The stock closed at $74.42, with some analysts valuing it 40% below fair value at $124.14, citing growth opportunities. However, its P/E ratio of 114.9x raises valuation concerns compared to industry peers.

MedAI 8/10

IPG Photonics Corporation Q3 2026 Earnings Call Summary

IPG Photonics reported Q3 2026 revenue growth of 15%, driven by industrial and advanced solutions. Advanced Solutions revenue surged 33% YoY, led by semiconductor and defense applications. The company expects medical business growth to double in 2-3 years post-Lumibird Medical acquisition. Q4 guidance accounts for moderation in China's battery capacity additions. The company maintains a strong balance sheet with $926M in cash and no debt.

$IPGPMedAI 8/10

IPG Photonics (IPGP) Q3 2026 Earnings Call Transcript

IPG Photonics (IPGP) reported Q3 2026 earnings, with revenue up 15% YoY to $288M. Industrial Solutions revenue grew 12% YoY, driven by welding and additive manufacturing. Advanced Solutions revenue increased 33% YoY, with strong growth in semiconductor and defense applications. The company announced the acquisition of Lumibird Medical, expected to close in Q4, expanding its medical laser platform. IPGP plans to host an Investor Day on March 2, 2027.